McMillan Office’s Johnson & Johnson JNJ Stock Holding History

McMillan Office’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5M	Sell	49,167 -100	-0.2%	-$23.3K	1.43%	14
2026 Q1	$12M	Hold	49,267	–	–	1.54%	13
2025 Q4	$10.2M	Buy	+49,267	New	+$9.74M	1.23%	17

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

McMillan Office's JNJ Position: Q2 2026 in Review

McMillan Office reduced its Johnson & Johnson (JNJ) stake by 0.2% in Q2 2026, selling an estimated $23.3K and leaving 49,167 shares worth $12.5M. The position accounts for 1.43% of the portfolio, ranked #14.

McMillan Office first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

McMillan Office held 49,167 shares of Johnson & Johnson worth $12.5M as of Q2 2026.
McMillan Office sold 100 Johnson & Johnson shares in Q2 2026, an estimated $23.3K.
Johnson & Johnson made up 1.43% of McMillan Office's portfolio in Q2 2026, its #14 holding.
McMillan Office first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.